nach oben

Tipp

The 2017 ESC/EACTS guidelines on the management of valvular heart disease

What is new and what has changed compared to the 2012 guidelines?

verfasst von: Helmut Baumgartner, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 5-6/2018

Einloggen, um Zugang zu erhalten

Summary

Numerous new data on the diagnosis and management of valvular heart disease published since 2012 made an update of the practice guidelines of the European Society of Cardiology and European Association of Cardiothoracic Surgery necessary. This was particularly the case for the use of catheter interventional treatment, indications for intervention in asymptomatic patients, medical treatment and organization of care. This review summarizes the most important changes in the recommendations.

Vorheriger Artikel Synthetic extracellular volume fraction—state of play

Nächster Artikel Impact of age on short- and long-term mortality of patients with ST-elevation myocardial infarction in the VIENNA STEMI network

Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91. CrossRefPubMed

Chambers JB, Prendergast B, Iung B, Rosenhek R, Zamorano JL, Piérard LA, Modine T, Falk V, Kappetein AP, Pibarot P, Sundt T, Baumgartner H, Bax JJ, Lancellotti P. Standards defining a ‘Heart Valve Centre’: ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint. Eur Heart J. 2017;38:2177–83. CrossRefPubMed

Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic assessment of aartic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18:254–75. CrossRef

Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017; https://doi.org/10.1093/eurheartj/ehx419.

Titel: The 2017 ESC/EACTS guidelines on the management of valvular heart disease
What is new and what has changed compared to the 2012 guidelines?
verfasst von: Helmut Baumgartner, MD
Publikationsdatum: 05.12.2017
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 5-6/2018
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-017-1297-5

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

The 2017 ESC/EACTS guidelines on the management of valvular heart disease

What is new and what has changed compared to the 2012 guidelines?

Summary

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5-6/2018

High liver density on CT imaging due to amiodarone toxicity

Veranstaltungstipps

Blood pressure profile is associated with microalbuminuria and retinopathy in hypertensive nondiabetic patients

Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling

Femoral access site closure without prior femoral angiography

Initial Slovenian experience with MitraClip therapy